Synthetic lethality of

Mycobacterium tuberculosis antimicrobial activity nicotinamide adenine dinucleotide pathogenesis respiration

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
30 Nov 2023
Historique:
medline: 30 11 2023
pubmed: 30 11 2023
entrez: 30 11 2023
Statut: aheadofprint

Résumé

In 2022, it was estimated that 10.6 million people fell ill, and 1.6 million people died from tuberculosis (TB). Available treatment is lengthy and requires a multi-drug regimen, which calls for new strategies to cure

Identifiants

pubmed: 38032200
doi: 10.1128/mbio.01045-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0104523

Commentaires et corrections

Type : UpdateOf

Auteurs

Yuanyuan Xu (Y)

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, USA.

Sabine Ehrt (S)

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, USA.

Dirk Schnappinger (D)

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, USA.

Tiago Beites (T)

Department of Microbiology and Immunology, Weill Cornell Medical College, New York, USA.

Classifications MeSH